Analytical Data
-
基因名
FAM131C
- Application
-
别名
C1orf117; F131C_HUMAN; FAM131C; Family with sequence similarity 131; member C; FLJ36766; Gm693; Protein FAM131C
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96AQ9
-
表达区间
1-280aa
-
氨基酸序列
MGSCVSRDLFTSAHKNCPMPQGADPLNPDLPSGRTPTVAPDCVIGKDKQMDFCWDPWQRCFQTTNGYLSDSRSRPGNYNVAALATSSLVGVVQSIKDHITKPTAMAQGRVAHLIEWKGWSAQRAGWELSPAEDEHYCCLPDELREARFAAGVAEQFAITEATLSAWSSLDEEELHPENSPQGIVQLQDLESIYLQDSLPSGPSQDDSLQAFSSPSPSPDSCPSPEDPPSTAGIPQPPSPELQHRRRLPGAQGPEGGTHPPGSLPSMDSGSLWEEDEVFYN
-
分子量
56.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM131C is a gene that encodes a protein believed to play a significant role in cellular signaling and various biological processes. Recent studies have highlighted its potential involvement in important cellular pathways, including those related to cell proliferation, differentiation, and survival. Dysregulation of FAM131C has been linked to several pathological conditions, including cancer, making it a candidate for further investigation in therapeutic contexts. Researchers are particularly interested in recombinant forms of the FAM131C protein to facilitate detailed studies on its structure-function relationships and interactions with other cellular components. By producing and characterizing recombinant FAM131C, scientists aim to elucidate its mechanisms of action, contributing valuable insights into the molecular underpinnings of diseases where this protein may be implicated. This research not only has the potential to enhance our understanding of FAM131C's biological roles but also to pave the way for novel therapeutic approaches targeting pathways influenced by this protein. Overall, studying recombinant FAM131C can provide crucial data that may inform future drug development and intervention strategies in related diseases.
